Skip to main content

Research programmes

Molecular Medicine Programme

Molecular Medicine Programme

The Molecular Medicine Programme investigates the molecular mechanisms of chronic diseases (obesity and metabolism, cardiovascular, neurology and cancer). The presence of common mechanisms and interactions between these diseases is becoming increasingly evident, common mechanisms that can be optimally addressed through the interaction of the different research groups of this programme.

Obesity
Molecular Metabolism - Rubén Nogueiras Pozo (Programme Coordinator)
Diabesity - Sulay Tovar Carro
Functional Obesomics - Carlos Diéguez González
Immunity and Small Molecules - Iria Gómez Touriño
Metabolic Homeostasis and Vascular Calcification - Ricardo Villa Bellosta
NeurObesity - Miguel López
Neuroendocrine Regulation of Metabolism - Ismael González García
Neurosciences
Brain Plasticity - Alba Vieites Prado
Cell and Molecular Neurobiology of Parkinson's Disease - Jose Luis Labandeira - Jannette Rodríguez Pallares - Ana Isabel Rodríguez-Pérez
Circadian and Glial Biology - Olga Barca Mayo
Gene Regulatory Control in Disease - Ashwin Woodhoo
Molecular Pathology of Rare Diseases - Jesús R. Requena
Ophthalmology and visual science - Francisco González García
Cardiovascular
Cardiovascular Area - José Ramón González Juanatey
Cell Signalling and Stress - Celia María Pombo Ramos
Laboratory for vascular biology - Juan Bautista Zalvide Torrente
Platelet Proteomics - Ángel García Alonso
Cancer
Cell cycle and Oncology - Anxo Vidal Figueroa
Cell senescence, cancer and aging - Manuel Collado Rodríguez
DNA Repair and Genome Integrity - Miguel González Blanco
Endocrine Oncology - Román Pérez-Fernández
Galician Oncological Research Group - Fernando Domínguez Puente
MitoPhenomics Lab - Aurora Gómez Durán
Molecular Oncology Laboratory - José Antonio Costoya Puente
Neoplasia & Endocrine Differentiation - Clara Álvarez Villamarín
Neuroendocrinology, metabolism and cáncer - Rosa Señarís
Stem Cells and Human Diseases - Miguel Fidalgo
Virus and Cancer - Carmen Rivas Vázquez

Integrative Translational Programme

Integrative Translational Programme

The Integrative Translational Programme investigates new drugs and new therapeutic strategies (drug screening, nanodelivery, genomic medicine, teragnostics...). The strategic groups that make up this programme will increase the translational potential of the groups in the first programme and other groups associated with the centre through the national and international networks and consortiums indicated above, promoting the transition towards precision medicine.